Theriva Biologics, Inc. Cash and Restricted Cash
Theriva Biologics, Inc. (TOVX) had Cash and Restricted Cash of $11.38 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.38M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.48M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.10M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.57M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $11.38M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $14.48M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $13.10M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $7.57M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $12.17M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $10.11M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $11.71M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $16.51M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $16.69M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $18.36M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $23.28M 10-K · filed 2026-03-12 |
| 2023-09-30 | $31.26M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $34.35M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $36.18M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $41.88M 10-K · filed 2025-03-06 |
| 2022-09-30 | $50.58M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $52.36M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $56.80M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $67.33M 10-K · filed 2024-03-25 |
| 2021-09-30 | $72.14M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $74.29M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $76.89M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $6.23M 10-K · filed 2023-03-30 |
| 2019-12-31 | $15.04M 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |